Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

CADLCADL
Showing 8 of 9 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in CANDEL THERAPEUTICS INC

Bank of New York Mellon Corp holds 191,701 shares of CADL (CANDEL THERAPEUTICS INC), worth $2M as of 2026-Q2. The position was increased (+40.7% shares). CADL represents 0.0% of Bank of New York Mellon Corp's portfolio.

Current Value

$2M

Current Shares

191,701

Total Value Change

+$1.7M

Total Shares Change

+146,723

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
191,701
+40.7%
$2M0.0%$10.30
34
2026-Q1
Increased
136,266
+43.1%
$667,7010.0%$4.91
33
2025-Q4
Increased
95,208
+0.7%
$537,9240.0%$5.71
24
2025-Q3
Increased
94,569
+8.9%
$482,3000.0%$5.40
26
2025-Q2
Increased
86,804
+42.9%
$439,2270.0%$4.90
32
2025-Q1
Increased
60,759
+35.1%
$343,2900.0%$5.95
31
2024-Q4
Increased
44,980
0.0%
$390,4250.0%$7.95
24
2024-Q3
Decreased
44,978
-17.4%
$311,7000.0%$7.21
0

Other major holders of CADL: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used